Pancreatic Cancer Research

ResearcherConsejo Nacional de Investigaciones Científicas y TécnicasActive in the last 2 years

Betina González

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9539-7757; OpenAlex author ID A5045139526. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2023: 1 paper · 2024: 2 papers

Papers 3

  1. Flurbiprofen inhibits cAMP transport by MRP4/ABCC4 increasing the potency of gemcitabine treatment in PDAC cell models. Co-author DOI 10.1016/j.ijbiomac.2024.136386↗
  2. The xenobiotic transporter ABCC4/MRP4 promotes epithelial mesenchymal transition in pancreatic cancer. Last author DOI 10.3389/fphar.2024.1432851↗
  3. [The mRNA vaccine for the treatment of pancreatic cancer is here to stay]. Co-author PMID 37582144↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ana Sahores · 3 shared papers, 2023–2024 · strength 0.56
  2. Carlos Alberto Davio · 3 shared papers, 2023–2024 · strength 0.56
  3. Agustín Yaneff · 3 shared papers, 2023–2024 · strength 0.56
  4. Nicolas Alejandro Fraunhoffer · 2 shared papers, 2023–2024 · strength 0.33
  5. Juan Iovanna · 2 shared papers, 2023–2024 · strength 0.33
  6. Nelson Dusetti · 2 shared papers, 2023–2024 · strength 0.33
  7. Ramiro Héctor Cerviño · 1 shared paper, 2024 · strength 0.23
  8. Samanta N. Gancedo · 1 shared paper, 2024 · strength 0.19
  9. Oscar Mazza · 1 shared paper, 2023 · strength 0.14
  10. María Eugenia Pasqualini · 1 shared paper, 2023 · strength 0.14
  11. María Noé Garcia · 1 shared paper, 2023 · strength 0.14
  12. Patricia Santofimia‐Castaño · 1 shared paper, 2023 · strength 0.14
  13. Eduardo Chuluyán · 1 shared paper, 2023 · strength 0.14
  14. Daniela Laura Papademetrio · 1 shared paper, 2023 · strength 0.14
  15. Daniel Grasso · 1 shared paper, 2023 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.